Abstract
Subclinical thyroid disease is currently a hot topic. The concept of subclinical hypothyroidism and hyperthyroidism has developed over the past 20 years or so since the advent of “sensitive” thyroid-stimulating hormone (TSH) testing. The development of the second-generation or sensitive TSH in the mid-1980s allowed for the use of TSH testing to screen for or diagnose both hypothyroidism and hyperthyroidism. This issue is discussed in more detail in Chapter 2.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected Sources
Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med 2001;345:512–516.
Fatourechi V. Subclinical thyroid disease. Mayo Clin Proc 2001;76:413–416
Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228–238.
Col NF, Surks MI, Daniels GH. Subclinical thyroid disease—Clinical applications. JAMA 2004;29:239–243.
Papi G, Pearce EN, Braverman LE, Betterle C, Roti E. A clinical and therapeutic approach to thyrotoxicosis with thyroid stimulating hormone suppression only. Am J Med 2005;118:349–361.
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
(2005). Subclinical Thyroid Disease. In: Thyroid Disease. Current Clinical Practice. Humana Press. https://doi.org/10.1385/1-59259-944-3:063
Download citation
DOI: https://doi.org/10.1385/1-59259-944-3:063
Publisher Name: Humana Press
Print ISBN: 978-1-58829-534-7
Online ISBN: 978-1-59259-944-8
eBook Packages: MedicineMedicine (R0)